MicroSigX Biotech Diagnostic Limited

MicroSigX Biotech Diagnostic Limited

Private
Hong KongHealthcare & Life Scienceshttps://microsigx.com/

Last Round

Grant

Jul 2, 2025

Company Overview

MicroSigX Biotech Diagnostic Limited is a biotechnology company that develops non-invasive, microbiome-based diagnostic solutions for diseases including colorectal cancer, autism spectrum disorder, and inflammatory bowel disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics, Clinical Trials

Business Model

B2B2C

Customer Profile

Hardware Sales, Data as a Service, Government Contracts

AI Layer

Application

Keywords

microbiome diagnosticscolorectal cancer screeningat-home testingnon-invasive diagnosticsstool testmetagenomicsAI diagnosticsmedical AImicrobial biomarkersgut health testbiomarker discoveryprecision medicineIBD diagnosticsASD diagnosticsPCR testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MicroSigX Biotech Diagnostic Limited Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MicroSigX Biotech Diagnostic Limited Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJul 2, 2025

MicroSigX Biotech Diagnostic Limited Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2025

    Received grant from the Innovation and Technology Commission.

MicroSigX Biotech Diagnostic Limited Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MicroSigX Biotech Diagnostic Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MicroSigX Biotech Diagnostic Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersHong Kong
Year Founded2024
Last FundingJul 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.